ATAI logo

Atai Life Sciences NV (ATAI)

Profile

Full Name

Atai Life Sciences N.V.

Ticker Symbol

ATAI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Germany

IPO

June 18, 2021

Indexes

Not included

Website

http://atai.com

Employees

54

Key Details

Price

$1.53(+0.66%)

Market cap

$303.41M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$308.00K(-1.91% YoY)

Annual EPS

-$0.93(-272.00% YoY)

PE ratio

-

Next earnings date

May 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.53
ATAI price is $1.53

30-Day Relative Volume

0.65
ATAI 30-day relative volume is 0.65

Price Performance

Price Most recent change

+0.66%
ATAI price was up +0.66% on Apr 24, 2025

Price YTD change

+15.04%
ATAI price is up +15.04% since January 1st

Price 1-year change

-16.85%
ATAI price is down -16.85% year-on-year

Price 3-year change

-69.22%
ATAI price is down -69.22% over the past 3 years

Price Range

Price All-time high

$22.91
ATAI price is currently -93.32% below its historical high of $22.91

Price 3-year low

$1.02
ATAI price is currently +49.27% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$303.41M
ATAI market capitalization is $303.41 million

Market cap 3-year change

-62.02%
ATAI market capitalization is down -62.02% over the past 3 years

Market cap All-time high

$3.03B
ATAI market capitalization is currently -90.00% below its historical high of $3.03 billion

Market cap sector rank

61.72%
ATAI market capitalization is higher than 61.72% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+18.45%
ATAI shares outstanding is up +18.45% year-on-year

Shares Outstanding 3-Year Change

+23.39%
ATAI shares outstanding is up +23.39% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.39
ATAI beta is 1.39

200-day SMA

$1.44
ATAI price is currently +6.24% above its 200-day simple moving average

50-day SMA

$1.56
ATAI price is currently -2.05% below its 50-day simple moving average

RSI

55.26
ATAI 14-day relative strength index is 55.26

Volume

0.65
ATAI 30-day relative volume is 0.65

ATR

$0.11
ATAI average true range is $0.11

10-day Historical Volatility

67.78%
ATAI 10-day historical volatility is 67.78%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$308.00K
ATAI annual revenue is $308.00 thousand

Revenue Analysts estimate

$250.00K
ATAI annual revenue is currently +23.20% higher than the consensus analysts' forecast

Revenue 1-year change

-1.91%
ATAI annual revenue is down -1.91% year-on-year

Revenue Sector rank

8.08%
ATAI annual revenue is higher than 8.08% of companies in Healthcare sector

EPS

EPS

-$0.93
ATAI annual earnings per share is -$0.93

EPS Analysts estimate

-$0.83
ATAI annual earnings per share is currently +12.50% higher than the consensus analysts' forecast

EPS 1-year change

-272%
ATAI annual earnings per share is down -272% year-on-year

EPS Sector rank

58.18%
ATAI annual earnings per share is higher than 58.18% of companies in Healthcare sector

Profit

Gross profit

-
ATAI annual gross profit value is unknown

Gross margin

-
ATAI annual gross profit margin value is unknown

Operating profit

-$102.17M
ATAI annual operating income is -$102.17 million

Operating margin

-33.17K%
ATAI annual operating profit margin is -33.17 thousand%

Net income

-$149.27M
ATAI annual net profit is -$149.27 million

Net margin

-48.46K%
ATAI annual net profit margin is -48.46 thousand%

Expenses

Total expenses

$102.47M
ATAI annual total expenses is $102.47 million

Operating expenses

$102.47M
ATAI annual total operating expenses is $102.47 million

Cost of goods sold

-
ATAI annual cost of goods sold value is unknown

Selling, general & administrative expenses

$47.54M
ATAI annual SGA is $47.54 million

Depreciation and amortization

$473.00K
ATAI annual depreciation & amortization is $473.00 thousand

Interest expense

$3.12M
ATAI annual interest expense is $3.12 million

Income tax

-$356.00K
ATAI annual income tax is -$356.00 thousand

EBIT & EBITDA

EBIT

-$145.28M
ATAI annual earnings before interest & taxes is -$145.28 million

EBITDA

-$144.81M
ATAI annual EBITDA is -$144.81 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$159.39M
ATAI annual total assets is $159.39 million

Non current assets

$79.26M
ATAI annual long term assets is $79.26 million

Current assets

$80.13M
ATAI annual total current assets is $80.13 million

Cash and cash equivalents

$17.50M
ATAI annual cash & cash equivalents is $17.50 million

Accounts receivable

-
ATAI annual accounts receivable value is unknown

Inventory

-
ATAI annual inventory value is unknown

Liabilities

Total liabilities

$42.83M
ATAI annual total liabilities is $42.83 million

Long term liabilities

$17.88M
ATAI annual total long term liabilities is $17.88 million

Current liabilities

$24.95M
ATAI annual total current liabilities is $24.95 million

Accounts payable

$2.62M
ATAI annual accounts payable is $2.62 million

Debt

Total debt

$24.71M
ATAI annual total debt is $24.71 million

Total debt 1-year change

+29.07%
ATAI annual total debt is up +29.07% year-on-year

Long term debt

$14.87M
ATAI annual long term debt is $14.87 million

Short term debt

$9.84M
ATAI annual short term debt is $9.84 million

Equity & Capital

Shareholders equity

$116.30M
ATAI annual stockholders equity is $116.30 million

Book value

$116.30M
ATAI annual book value is $116.30 million

Retained earnings

-$700.21M
ATAI annual retained earnings is -$700.21 million

Working capital

$55.17M
ATAI annual working capital is $55.17 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$82.44M
ATAI annual cash flow from operations is -$82.44 million

Cash from operations 1-year change

+2%
ATAI annual cash flow from operations is up +2% year-on-year

Cash from investing

$59.17M
ATAI annual cash flow from investing activities is $59.17 million

Cash from investing 1-year change

+211.03%
ATAI annual cash flow from investing activities is up +211.03% year-on-year

Cash from financing

$5.37M
ATAI annual cash flow from financing activities is $5.37 million

Cash from financing 1-year change

+164.32%
ATAI annual cash flow from financing activities is up +164.32% year-on-year

CAPEX

CAPEX

$95.00K
ATAI annual capital expenditures is $95.00 thousand

CAPEX 1-year change

-83.9%
ATAI annual capital expenditures is down -83.9% year-on-year

Free Cash Flow

Free cash flow

-$82.53M
ATAI annual free cash flow is -$82.53 million

Free cash flow 1-year change

+2.57%
ATAI annual free cash flow is up +2.57% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ATAI annual gross profit margin value is unknown

Operating margin

-33.17K%
ATAI annual operating profit margin is -33.17 thousand%

Net margin

-48.46K%
ATAI annual net profit margin is -48.46 thousand%

ROA & ROE

ROA

-65.92%
ATAI annual return on assets is -65.92%

ROE

-82.73%
ATAI annual return on equity is -82.73%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ATAI price to earnings ratio value is unknown

PE ratio Sector rank

-
ATAI price to earnings ratio is unknown

PB Ratio

PB ratio

2.61
ATAI price to book ratio is 2.61

PB ratio Sector rank

68.38%
ATAI price to book ratio is higher than 68.38% of companies in Healthcare sector

PS Ratio

PS ratio

985.09
ATAI price to sales ratio is 985.09

PS ratio Sector rank

98.7%
ATAI price to sales ratio is higher than 98.7% of companies in Healthcare sector

Enterprise value

Enterprise value

$310.61M
ATAI enterprise value is $310.61 million

Enterprise value Sector rank

62.39%
ATAI enterprise value is higher than 62.39% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.14
ATAI EV/EBITDA is -2.14

EV/EBITDA Sector rank

33.6%
ATAI EV/EBITDA is higher than 33.6% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.21
ATAI annual current ratio is 3.21

Quick ratio

-
ATAI annual quick ratio value is unknown

Leverage

Debt to equity

0.20
ATAI annual debt to equity ratio is 0.20

Interest coverage ratio

-46.50
ATAI annual interest coverage ratio is -46.50

Risk & Stability

Piotroski F-Score

-
ATAI piotroski f-score value is unknown

Altman Z-Score

-4.49
ATAI altman z-score is -4.49

Analyst ratings

Recent major analysts updates

Mar 19, 25 HC Wainwright & Co.
Buy
Feb 13, 25 HC Wainwright & Co.
Buy
Nov 18, 24 HC Wainwright & Co.
Buy
Nov 18, 24 Canaccord Genuity
Buy

Institutional Ownership

Similar stocks

MXCT logo
MaxCyte (MXCT)
DH logo
Definitive Healthcare (DH)
ATYR logo
aTyr Pharma (ATYR)
MRVI logo
Maravai LifeSciences Holdings (MRVI)
RNAC logo
Cartesian Therapeutics (RNAC)
Anbio Biotechnology Class A (NNNN)
ATXS logo
Astria Therapeutics (ATXS)
CMPX logo
Compass Therapeutics (CMPX)
EBS logo
Emergent BioSolutions (EBS)
  • What is the ticker symbol for Atai Life Sciences NV?
  • Does Atai Life Sciences NV pay dividends?
  • What sector is Atai Life Sciences NV in?
  • What industry is Atai Life Sciences NV in?
  • What country is Atai Life Sciences NV based in?
  • When did Atai Life Sciences NV go public?
  • Is Atai Life Sciences NV in the S&P 500?
  • Is Atai Life Sciences NV in the NASDAQ 100?
  • Is Atai Life Sciences NV in the Dow Jones?
  • When was Atai Life Sciences NV's last earnings report?
  • When does Atai Life Sciences NV report earnings?
  • Should I buy Atai Life Sciences NV stock now?

What is the ticker symbol for Atai Life Sciences NV?

The ticker symbol for Atai Life Sciences NV is NASDAQ:ATAI

Does Atai Life Sciences NV pay dividends?

No, Atai Life Sciences NV does not pay dividends

What sector is Atai Life Sciences NV in?

Atai Life Sciences NV is in the Healthcare sector

What industry is Atai Life Sciences NV in?

Atai Life Sciences NV is in the Biotechnology industry

What country is Atai Life Sciences NV based in?

Atai Life Sciences NV is headquartered in Germany

When did Atai Life Sciences NV go public?

Atai Life Sciences NV's initial public offering (IPO) was on June 18, 2021

Is Atai Life Sciences NV in the S&P 500?

No, Atai Life Sciences NV is not included in the S&P 500 index

Is Atai Life Sciences NV in the NASDAQ 100?

No, Atai Life Sciences NV is not included in the NASDAQ 100 index

Is Atai Life Sciences NV in the Dow Jones?

No, Atai Life Sciences NV is not included in the Dow Jones index

When was Atai Life Sciences NV's last earnings report?

Atai Life Sciences NV's most recent earnings report was on Nov 13, 2024

When does Atai Life Sciences NV report earnings?

The next expected earnings date for Atai Life Sciences NV is May 15, 2025

Should I buy Atai Life Sciences NV stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page